Reata Pharmaceuticals, Inc. - stock earnings
Stock symbol RETA is outdated, potentially delisted? Maybe it is available on other exchange?
RETA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | 193.0 million USD | 22.7 million USD |
| 2022Q4 | -85.5 million USD | ? USD |
| 2022Q3 | -79.0 million USD | 540000 USD |
| 2022Q2 | -73.6 million USD | 762000 USD |
| 2022Q1 | -73.8 million USD | 914000 USD |
| 2021Q4 | -85.4 million USD | 933000 USD |
| 2021Q3 | -71.8 million USD | 7.4 million USD |
| 2021Q2 | -72.7 million USD | 2.2 million USD |
| 2021Q1 | -67.5 million USD | 944000 USD |
| 2020Q4 | -65.8 million USD | 3.2 million USD |
| 2020Q3 | -65.5 million USD | 1.4 million USD |
| 2020Q2 | -67.6 million USD | 3.1 million USD |
RETA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -311.9 million USD | 2.2 million USD |
| 2021 | -297.4 million USD | 11.5 million USD |
| 2020 | -247.8 million USD | 9.0 million USD |
| 2019 | -290.2 million USD | 26.5 million USD |
| 2018 | -80.5 million USD | 53.6 million USD |
| 2017 | -47.7 million USD | 48.1 million USD |
RETA
Price: $172.36
52 week price:
Earnings Per Share: -4.77 USD
P/E Ratio: -13.24
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 653600
Ebitda: -11.7 millionMarket Capitalization: 3.9 billion